Pregnancy Category: UK
ClassificationTherapeutic: nonopioid analgesics
Dietary management of osteoarthritis; considered to be a medical food product.
Anti-inflammatory and analgesic properties related to inhibition of prostaglandin synthesis by inhibiting cyclo-oxygenase (not COX-2 selective) and other mediators of inflammation.
Decreased pain/inflammation associated with osteoarthritis, with improved mobility.
Absorption: Some intestinal conversion prior to absorption, remainder unknown.
Metabolism and Excretion: Mostly metabolized by the liver.
Time/action profile (analgesic effect)
|PO||within 1–2 hr||unknown||12 hr|
Contraindicated in: Hypersensitivity; Obstetric / Lactation / Pediatric: Not recommended.
Use Cautiously in: History of GI bleeding.
Adverse Reactions/Side Effects
- ↑ BP
- ↑ in varicose veins
- GI upset
Drug-Drug interactionNone noted.
Oral (Adults) 250 mg every 12 hr (up to 250 mg three times daily has been used).
Capsules: 250 mg
- Assess pain (note type, location, and intensity), range of motion, degree of swelling, and stiffness in affected joints before and periodically during therapy.
Potential Nursing DiagnosesChronic pain (Indications)
- Oral: Administer flavocoxid twice daily.
- Instruct patient to take flavocoxid as directed. Do not increase does without consulting health care professional.
- Decrease in pain and stiffness, and improved mobility in patients with osteoarthritis.
an oral nutritional supplement.
indication This drug is used for dietary management of osteoarthritis.
contraindication Known hypersensitivity to this drug prohibits its use.
adverse effects Adverse effects of this drug include hypertension, increase in varicose veins, psoriasis, and fluid accumulation in the knees.